Literature DB >> 25476120

Latent class analysis of discordance between results of drug use assessments in the CATIE data.

Kiersten L Johnson1, Sarah L Desmarais2, Marvin S Swartz3, Richard A Van Dorn4.   

Abstract

OBJECTIVE: The primary aim is to examine concordant/discordant results of drug use assessments in adults with schizophrenia.
METHODS: Latent class analysis and multinomial logistic regression were used to examine concordance/discordance between drug use measures and identify characteristics differentiating participants across classes.
RESULTS: Four classes - non-users, users, probable users, and RIA discordant - fit best. Age, sex, race/ethnicity, and psychiatric symptoms differed significantly across classes.
CONCLUSIONS: Findings showed that discordance between results occurs at non-trivial rates and is, in part, attributable to individual characteristics. Results suggest the need for strategies to limit discordance and improve detection of drug use in adults with schizophrenia.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Assessment; Drug use; Latent class analysis; Schizophrenia

Mesh:

Substances:

Year:  2014        PMID: 25476120      PMCID: PMC4827431          DOI: 10.1016/j.schres.2014.11.016

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  20 in total

1.  Accuracy of self-report, biological tests, collateral reports and clinician ratings in identifying substance use disorders among adults with schizophrenia.

Authors:  Sarah L Desmarais; Richard A Van Dorn; Brian G Sellers; M Scott Young; Marvin S Swartz
Journal:  Psychol Addict Behav       Date:  2012-12-31

Review 2.  A review of research on residential programs for people with severe mental illness and co-occurring substance use disorders.

Authors:  Mary F Brunette; Kim T Mueser; Robert E Drake
Journal:  Drug Alcohol Rev       Date:  2004-12

3.  Double jeopardy: schizophrenia and substance use.

Authors:  C D Swofford; G Scheller-Gilkey; A H Miller; B Woolwine; R Mance
Journal:  Am J Drug Alcohol Abuse       Date:  2000-08       Impact factor: 3.829

4.  A national study of violent behavior in persons with schizophrenia.

Authors:  Jeffrey W Swanson; Marvin S Swartz; Richard A Van Dorn; Eric B Elbogen; H Ryan Wagner; Robert A Rosenheck; T Scott Stroup; Joseph P McEvoy; Jeffrey A Lieberman
Journal:  Arch Gen Psychiatry       Date:  2006-05

5.  Detection of illicit substance use among persons with schizophrenia by radioimmunoassay of hair.

Authors:  Marvin S Swartz; Jeffrey W Swanson; Michael J Hannon
Journal:  Psychiatr Serv       Date:  2003-06       Impact factor: 3.084

6.  Diagnosis of alcohol use disorders in schizophrenia.

Authors:  R E Drake; F C Osher; D L Noordsy; S C Hurlbut; G B Teague; M S Beaudett
Journal:  Schizophr Bull       Date:  1990       Impact factor: 9.306

7.  The utility of drug testing in epidemiological research: results from a general population survey.

Authors:  Michael Fendrich; Timothy P Johnson; Joseph S Wislar; Amy Hubbell; Vina Spiehler
Journal:  Addiction       Date:  2004-02       Impact factor: 6.526

8.  Comparison between self-report and hair analysis of illicit drug use in a community sample of middle-aged men.

Authors:  David M Ledgerwood; Bruce A Goldberger; Nathan K Risk; Collins E Lewis; Rumi Kato Price
Journal:  Addict Behav       Date:  2008-05-08       Impact factor: 3.913

9.  Alcohol use and abuse in schizophrenia. A prospective community study.

Authors:  R E Drake; F C Osher; M A Wallach
Journal:  J Nerv Ment Dis       Date:  1989-07       Impact factor: 2.254

10.  Estimating the optimal dynamic antipsychotic treatment regime: Evidence from the sequential multiple assignment randomized CATIE Schizophrenia Study.

Authors:  Susan M Shortreed; Erica E M Moodie
Journal:  J R Stat Soc Ser C Appl Stat       Date:  2012-05-31       Impact factor: 1.864

View more
  1 in total

1.  Motivation deficits and use of alcohol and illicit drugs among individuals with schizophrenia.

Authors:  Amber L Bahorik; Catherine G Greeno; Gerald Cochran; Jack R Cornelius; Shaun M Eack
Journal:  Psychiatry Res       Date:  2017-04-05       Impact factor: 3.222

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.